看來載入頁面時發生了錯誤.
我們的團隊已收到通知，但若此問題持續，請透過電郵支援widget工具聯絡我們。
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM Revenue Multiple | 5.9x - 6.5x | 6.2x |
| Selected Fwd Revenue Multiple | 5.9x - 6.5x | 6.2x |
| Fair Value | €161.93 - €181 | €171.47 |
| Upside | -7.9% - 2.9% | -2.5% |
| Benchmarks | Ticker | Full Ticker |
|---|---|---|
| Revvity, Inc. | RVTY | NYSE:RVTY |
| Bio-Techne Corporation | TECH | NasdaqGS:TECH |
| Agilent Technologies, Inc. | A | NYSE:A |
| Thermo Fisher Scientific Inc. | TMO | NYSE:TMO |
| Mesa Laboratories, Inc. | MLAB | NasdaqGS:MLAB |
| Danaher Corporation | DAP | DB:DAP |
| Select LTM Revenue Multiple | ||||||||
| Benchmark Companies | ||||||||
| RVTY | TECH | A | TMO | MLAB | DAP | |||
| NYSE:RVTY | NasdaqGS:TECH | NYSE:A | NYSE:TMO | NasdaqGS:MLAB | DB:DAP | |||
| Historical Revenue Growth | ||||||||
| 5Y CAGR | -0.9% | 10.2% | 4.7% | 10.9% | 16.0% | 5.9% | ||
| 3Y CAGR | -10.4% | 7.6% | 1.0% | 3.0% | 17.3% | -1.3% | ||
| Latest Twelve Months | 1.6% | 4.5% | -3.0% | 1.0% | 11.7% | 0.3% | ||
| Historical EBIT Profit Margin | ||||||||
| 5 Year Average Margin | 23.5% | 23.6% | 22.1% | 20.9% | 4.7% | 24.4% | ||
| Prior Fiscal Year | 13.9% | 24.7% | 20.7% | 17.4% | 1.5% | 22.5% | ||
| Latest Fiscal Year | 14.9% | 21.2% | 23.7% | 18.0% | 1.7% | 21.6% | ||
| Latest Twelve Months | 15.5% | 20.5% | 23.5% | 18.3% | 8.7% | 21.4% | ||
| Current Trading Multiples | ||||||||
| EV / LTM Revenue | 4.87x | 6.64x | 5.06x | 4.39x | 3.48x | 6.64x | ||
| EV / LTM EBIT | 31.3x | 32.3x | 21.5x | 24.0x | 40.2x | 30.9x | ||
| Price / LTM Sales | 4.08x | 6.67x | 4.74x | 3.73x | 2.72x | 5.98x | ||
| Low | Mid | High | ||||||
| Benchmark EV / LTM Revenue | 3.48x | 4.87x | 6.64x | |||||
| Historical EV / LTM Revenue | 6.72x | 8.65x | 9.28x | |||||
| Selected EV / LTM Revenue | 5.90x | 6.21x | 6.52x | |||||
| (x) LTM Revenue | 23,820 | 23,820 | 23,820 | |||||
| (=) Implied Enterprise Value | 140,531 | 147,927 | 155,323 | |||||
| (-) Non-shareholder Claims * | (15,592) | (15,592) | (15,592) | |||||
| (=) Equity Value | 124,939 | 132,335 | 139,731 | |||||
| (/) Shares Outstanding | 715.7 | 715.7 | 715.7 | |||||
| Implied Value Range | 174.58 | 184.91 | 195.25 | |||||
| FX Rate: USD/EUR | 1.1 | 1.1 | 1.1 | Market Price | ||||
| Implied Value Range (Trading Cur) | 154.41 | 163.55 | 172.69 | 175.84 | ||||
| Upside / (Downside) | -12.2% | -7.0% | -1.8% | |||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | RVTY | TECH | A | TMO | MLAB | DAP | |
| Enterprise Value | 13,480 | 7,940 | 32,871 | 187,943 | 826 | 157,868 | |
| (+) Cash & Short Term Investments | 1,138 | 178 | 1,467 | 5,947 | 32 | 1,993 | |
| (+) Investments & Other | 0 | 260 | 173 | 352 | 0 | 0 | |
| (-) Debt | (3,325) | (395) | (3,540) | (34,259) | (212) | (17,577) | |
| (-) Other Liabilities | 0 | 0 | 0 | (95) | 0 | (8) | |
| (-) Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 11,293 | 7,982 | 30,971 | 159,888 | 647 | 142,276 | |
| (/) Shares Outstanding | 120.1 | 158.1 | 285.1 | 377.5 | 5.4 | 715.7 | |
| Implied Stock Price | 93.99 | 50.49 | 108.63 | 423.55 | 119.06 | 198.80 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.13 | |
| Implied Stock Price (Trading Cur) | 93.99 | 50.49 | 108.63 | 423.55 | 119.06 | 175.84 | |
| Trading Currency | USD | USD | USD | USD | USD | EUR | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.13 | |